REFERENCES
- Satyannrana S., Ganaga S., Singh J. Transport Through Rat Skin from Transdermal Patch Formulations. Pharmazie 1993; 48: 467–468
- Morgan T.M., Reed B.L., Finnin B.C. Enhanced Skin Permeation of Sex Hormones with Novel Topical Spray Vehicles. J. Pharm. Sci. 1998; 87(1)1213–1218
- Morgan T.M., Parr R.A., Reed B.L., Finnin B.C. Enhanced Transdermal Delivery of Sex Hormones in Swine with a Novel Topical Aerosol. J. Pharm. Sci. 1998; 87(1)1219–1225
- Salehian B., Wand C., Alexander G., Davidson T., McDonald V., Berman N., Dudley R.E., Zikl F., Verdloff R.S. Pharmacokinetics, Bioefficacy and Safety of Sublingual Testosterone Cyclodextrin in Hypogonadal Men: Comparison to Testosterone Enanthate-A Clinical Research Center Study. J. Clin. Endocr. Metab. 1995; 80(12)3567–3575
- Kesler D.J., Christenson D.C., Wallace M.E. The Effect of Esterification on Their Release of Testosterone and Estradiol from Silicone Implants. Drug Dev. Ind. Pharm. 1996; 22(3)275–279
- Jordan W.P. Allergy and Topical Irritation Associated with Transdermal Testosterone Administration: A Comparison of Scrotal and Nonscrotal Transdermal Systems. Am. J. Contact Derm. 1997; 8: 108–113
- Misra A., Raghuvanshi R.S., Ganga S., Diwan M., Talwar G.P., Singh O. Formulation of a Transdermal System for Biphasic Delivery of Testosterone. J. Contr. Rel. 1995; 39: 1–7
- Cichon R., Janicki S. Effect of Polyoxyethylene Glycols (PEG) on Properties of the Matrix Model of Transdermal Therapeutic System (TTS) with Testosterone. Pharmazie 1991; 46: 719–723
- Variankaval N.E., Jacob K.I., Dinh S.M. Crystallization of Beta-estradiol in an Acrylic Transdermal Drug Delivery System. J. Biomed. Mater. Res. 1999; 44(4)397–406
- Jeans C.W., Heard C.M. A Therapeutic Dose of Primaquine can be Delivered Across Excised Human Skin from Simple Transdermal Patches. Int. J. Pharm. 1999; 189: 1–6
- Kim M.K., Lee C.H., Kim D.D. Rat Skin Permeation of Testosterone and Its Ester Derivatives. J. Pharm. Pharmacol. 2000; 52(4)369–375
- Kim M.K., Zhao H., Lee C.H., Kim D.D. Formulation of a Reservoir-Type Testosterone Transdemal Delivery System. Int. J. Pharm. 2001; 219: 51–59